These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 578375)

  • 1. T3 toxicosis in children.
    Harland PC; McArthur RG; Fawcett DM
    Acta Paediatr Scand; 1977 Jul; 66(4):525-8. PubMed ID: 578375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
    Izumi M; Larsen PR
    Metabolism; 1978 Apr; 27(4):449-60. PubMed ID: 580305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
    Hollander CS; Shenkman L; Mitsuma T; Asper SP
    Johns Hopkins Med J; 1972 Aug; 131(2):184-8. PubMed ID: 5068365
    [No Abstract]   [Full Text] [Related]  

  • 5. Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
    Takamatsu J; Sugawara M; Kuma K; Kobayashi A; Matsuzuka F; Mozai T; Hershman JM
    Ann Intern Med; 1984 Mar; 100(3):372-5. PubMed ID: 6546484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum free thyroid hormones in T3-toxicosis: a study of 35 patients.
    Ferrari C; Romussi M; Rampini P; Benco R; Boghen M; Paracchi A; Frezzati S
    J Endocrinol Invest; 1983 Feb; 6(1):55-8. PubMed ID: 6687730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of simultaneous T3, T4, and TSH measurements for management of graves' disease in children.
    Golden MP; Kaplan SA; Lippe BM; Lee WN
    Pediatrics; 1977 May; 59(5):762-7. PubMed ID: 577011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
    Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
    J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of routine serum-triiodothyronine estimation in diagnosis of thyrotoxicosis.
    Shalet SM; Beardwell CG; Lamb AM; Gowland E
    Lancet; 1975 Nov; 2(7943):1008-10. PubMed ID: 53496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
    Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K
    J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
    Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum free thyroxine in patients with T3-toxicosis.
    Martino E; Pacchiarotti A; Aghini-Lombardi F; Grasso L; Bambini G; Baschieri L; Pinchera A
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):354-9. PubMed ID: 4072576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
    Sobrinho LG; Limbert ES; Santos MA
    J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum T3 level in the patients with hyperthyroidism after therapy.
    Hachiya T; Ochi Y; Yoshimura M; Miyazaki T
    Endocrinol Jpn; 1975 Jun; 22(3):255-60. PubMed ID: 1175526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
    Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
    Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of thyroid hormones in Hashimoto's thyroiditis.
    Gharib H; Wahner HW; McConahey WM
    Mayo Clin Proc; 1972 Mar; 47(3):175-9. PubMed ID: 4622285
    [No Abstract]   [Full Text] [Related]  

  • 19. Triiodothyronine production in Graves' hyperthyroidism.
    Woeber KA
    Thyroid; 2006 Jul; 16(7):687-90. PubMed ID: 16889493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.